Burden of cancer in Poland analysed using potential years of life lost

被引:3
作者
Orlewska, Katarzyna [1 ]
Stepien, Renata [1 ,2 ]
Orlewska, Ewa [2 ]
机构
[1] Med Univ Warsaw, Fac Med 1, 61 Zwirki & Wigury St, PL-02091 Warsaw, Poland
[2] Jan Kochanowski Univ, Fac Med & Hlth Sci, Kielce, Poland
来源
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY | 2020年 / 24卷 / 01期
关键词
cancer; burden of disease; mortality; potential years of life lost; UNITED-STATES;
D O I
10.5114/wo.2020.93680
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim of the study: The aim was to assess the impact of the most frequent cancer-related causes of death in Poland by estimating the years of potential life lost (YPLL) and to compare different measures of the burden of cancer deaths on the population. Material and methods: Mortality rate, YPLL and mean YPLL were calculated for the 11 most frequently recorded cancer-related causes of death in Poland. YPLL were measured applying the up-to-date reference life tables proposed by the Institute for Health Metrics and Evaluation and used in the Global Burden of Disease study (GBD 2015). Absolute numbers of cancer deaths by site, gender and five-year age groups were obtained from the Polish National Cancer Registry (2015). Results: In 2015 the total YPLL amounted to 1,990,457, with 23.6% from lung and bronchial cancer. Mean YPLL was 19.79 years and varied considerably according to tumour site (26.12 [brain] - 14.3 [prostate]). Three tumour sites (brain, ovarian and kidney) are positioned higher according to mean YPLL than according to YPLL percentage and mortality percentage. Conclusions: Our results draw attention to the impact of cancer on society and individual patients. Addressing research efforts to prevention and/or treatment of major YPLL causes could result in a substantial impact on general life expectancy.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 14 条
  • [1] Years of life lost as a measure of cancer burden on a national level
    Brustugun, O. T.
    Moller, B.
    Helland, A.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 111 (05) : 1014 - 1020
  • [2] Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds
    Burnet, NG
    Jefferies, SJ
    Benson, RJ
    Hunt, DP
    Treasure, FP
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (02) : 241 - 245
  • [3] An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values
    Carter, Ashley J. R.
    Delarosa, Beverly
    Hur, Hannah
    [J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2015, 13
  • [4] A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding
    Carter, Ashley J. R.
    Nguyen, Cecine N.
    [J]. BMC PUBLIC HEALTH, 2012, 12
  • [5] Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009
    de Blank, Peter M.
    Ostrom, Quinn T.
    Rouse, Chaturia
    Wolinsky, Yingli
    Kruchko, Carol
    Salcido, Joanne
    Barnholtz-Sloan, Jill S.
    [J]. CANCER MEDICINE, 2015, 4 (04): : 608 - 619
  • [6] Didkowska J, 2017, CANC POLAND 2015
  • [7] Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012
  • [8] Years of life lost due to cancer in a cohort study in Japan
    Pham, Truong-Minh
    Fujino, Yoshihisa
    Ide, Reiko
    Tokui, Noritaka
    Kubo, Tatsuhiko
    Mizoue, Tetsuya
    Ogimoto, Itsuro
    Matsuda, Shinya
    Yoshimura, Takesumi
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2009, 19 (02) : 189 - 192
  • [9] Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010
    Rouse, Chaturia
    Gittleman, Haley
    Ostrom, Quinn T.
    Kruchko, Carol
    Barnholtz-Sloan, Jill S.
    [J]. NEURO-ONCOLOGY, 2016, 18 (01) : 70 - 77
  • [10] Serbia within the European context: An analysis of premature mortality
    Milicevic M.S.
    Bjegovic V.
    Terzic Z.
    Vukovic D.
    Kocev N.
    Marinkovic J.
    Vasic V.
    [J]. Population Health Metrics, 7 (1)